Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Maxiflo-M 250µg/6µg


Contraindicated
Reproductive toxicity in animals

Contraindicated
Maxiflo-M 250µg/6µg :
Type Medicine Non Marketed
Originator G
Agent Droguerie de l'Union
Distributor Droguerie de l'Union
Laboratory Cipla
Responsible Party Cipla Ltd
Origin India
Manufacturer Cipla Ltd
Manufacturing Type G
Origin India
ATC R03AK11

Your comment will appear shortly after approval

Maxiflo-M 250µg/6µg :

Revision Date : 08/06/2010


Effect Frequency
Adrenal suppression Very rare
Angioedema (Angioneurotic oedema) (Quincke oedema) Very rare
Anxiety Very rare
Bone density decreased Very rare
Bronchospasm Very rare
Bronchospasm paradoxical Very rare
Candida albicans infection Very Common
Cataract Very rare
Contusion Common
Cushing's syndrome Very rare
Dyspnoea (dyspnea) Very rare
Glaucoma Very rare
Growth retardation Very rare
Hoarseness Common
Hyperactivity (Increased activity) Very rare
Hyperglycaemia Very rare
Hypersensitivity reactions Uncommon
Irritability Very rare
Oral candidiasis Very Common
Oropharyngeal candidiasis Very Common
Respiratory disorder Very rare
Sleep disorder (Sleep disturbance) Very rare
Wheezing Very rare

Different Units By MoH Code

Revision Date : 01/02/2012

Maxiflo-M 250µg/6µg Maxiflo-M 250µg/6µg Maxiflo-M 250µg/6µg Maxiflo-M 250µg/6µg Maxiflo-M 250µg/6µg Maxiflo-M 250µg/6µg Maxiflo-M 250µg/6µg Maxiflo-M 250µg/6µg

Maxiflo-M 250µg/6µg  MoH 7447 :
Form Inhalation solution
Packaging Metered dose inhaler
Package Size 120 doses
Strength 250µg/6µg
NSSF ✘
Quarantine ✘
Reg. Number 166514/11
Submission date 01/01/2011
Registration Year 2014
Archived Date 03/05/2023
Barcode 8901117135550


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info